|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/135 | |
| A61P 31/12 | |||
| A61P 31/16 | |||
| A61P 31/22 | |||
| A61P 31/14 |
| (11) | Number of the document | 1201236 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00940873.3 |
| Date of filing the European patent application | 2000-06-28 | |
| (97) | Date of publication of the European application | 2002-05-02 |
| (45) | Date of publication and mention of the grant of the patent | 2006-09-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2000/004286 |
| Date | 2000-06-28 |
| (87) | Number | WO 2001/001978 |
| Date | 2001-01-11 |
| (30) | Number | Date | Country code |
| 18529799 | 1999-06-30 | JP |
| (72) |
MATSUMORI, Akira, JP
|
| (73) |
Mitsubishi Pharma Corporation,
6-9, Hiranomachi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-0046,
JP
Matsumori, Akira, 16-22, Segawa 5-chome, Minoh-shi, Osaka 562-0045, JP |
| (54) | USE OF 2-AMINO-2-(2-(4-OCTYLPHENYL)ETHYL)PROPANE-1,3-DIOL FOR PREVENTING OR TREATING VIRAL MYOCARDITIS |
| USE OF 2-AMINO-2-(2-(4-OCTYLPHENYL)ETHYL)PROPANE-1,3-DIOL FOR PREVENTING OR TREATING VIRAL MYOCARDITIS |